In Prevention of organ rejection in transplant patients Keygraf 2 Capsule belongs to a group of medicines known as immunosuppressants. Organ rejection happens when your immune system treats the new organ as an invader and attacks it. This medicine weakens your immune response (which usually fights infection) and reduces the chance of your body attacking the transplanted organ. It is used in combination with other medicines to make it much more likely that your transplant operation will be successful. You should continue taking the medicine and should not stop it until your doctor says so.
It is unsafe to consume alcohol with Keygraf 2 Capsule.
Keygraf 2 Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Keygraf 2 Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Keygraf 2 Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Keygraf 2 Capsule should be used with caution in patients with kidney disease. Dose adjustment of Keygraf 2 Capsule may be needed. Please consult your doctor.
Keygraf 2 Capsule should be used with caution in patients with liver disease. Dose adjustment of Keygraf 2 Capsule may be needed. Please consult your doctor.
If you miss a dose of Keygraf 2 Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Advaith Life Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sanzyme Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Rlv Lifesciences Private Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Taj Pharma India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Johnlee Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alniche Life Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Mylan Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Akognos Life Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Micro Labs Ltd || ₹14.5/tablet (25% cheaper)